Inicio>>Signaling Pathways>> Apoptosis>>Gemcitabine monophosphate

Gemcitabine monophosphate

Catalog No.GC47396

El monofosfato de gemcitabina (gemcitabina 5′-fosfato) es uno de los intermediarios activos de la gemcitabina. El monofosfato de gemcitabina muestra efectos anticancerÍgenos sinérgicos.

Products are for research use only. Not for human use. We do not sell to patients.

Gemcitabine monophosphate Chemical Structure

Cas No.: 116371-67-6,1638288-31-9

Tamaño Precio Disponibilidad Cantidad
500 μg
170,00 $
Disponible
1 mg
321,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Gemcitabine monophosphate is a monophosphate form of the deoxycytidine analog gemcitabine .1 It has synergistic effects when used in nanoparticle form in combination with cisplatin nanoparticles in vitro at a one-to-one molar ratio (IC50s = 5.95 and 34.8 for the nanoparticle combination and gemcitabine monophosphate alone, respectively). In a stroma-rich mouse xenograft model, the nanoparticle combination of gemcitabine and cisplatin inhibits tumor growth and increases apoptosis.

1.Zhang, J., Miao, L., Guo, S., et al.Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma modelJ. Control. Release18290-96(2014)

Reseñas

Review for Gemcitabine monophosphate

Average Rating: 5 ★★★★★ (Based on Reviews and 12 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Gemcitabine monophosphate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.